Stuart J. Tipping
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation
Papers in
- Oncology 3
- Cancer Treatment and Pharmacology 2
- Polyomavirus and related diseases 1
-
- Cancer therapeutics and mechanisms 1
- Co-authors
- Daniel M. Jacobson (1 shared paper)Charles E. Thirkill (1 shared paper)David A. Van Echo (2 shared papers)Eve A. Olman (1 shared paper)Margaret Whitacre (1 shared paper)Joseph Aisner (1 shared paper)Merrill J. Egorin (1 shared paper)Bruce Thompson (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Annals of Neurology (1 paper)American Journal of Clinical Oncology (1 paper)PubMed (5 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Stuart J. Tipping
9 papers receiving 563 citations
Peers
Comparison fields: 5 of 54
- Oncology 244
- Pathology and Forensic Medicine 136
- Neurology 100
- Ophthalmology 55
- Hematology 45
Countries citing papers authored by Stuart J. Tipping
This map shows the geographic impact of Stuart J. Tipping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Tipping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Tipping more than expected).
Fields of papers citing papers by Stuart J. Tipping
This network shows the impact of papers produced by Stuart J. Tipping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Tipping. The network helps show where Stuart J. Tipping may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart J. Tipping, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function. | 1984 | 259 |
| 2 | 1990 | 145 | |
| 3 | 1999 | 129 | |
| 4 | 2006 | 28 | |
| 5 | 2002 | 10 | |
| 6 | Phase II evaluation of spirogermanium in advanced ovarian carcinoma. | 1983 | 5 |
| 7 | Phase II study of spirogermanium in patients with advanced carcinoma of the cervix. | 1985 | 5 |
| 8 | Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck. | 1984 | 2 |
| 9 | High dose methotrexate infusion with leucovorin rescue for treatment of ectopic pregnancy. | 1995 | 1 |
About Stuart J. Tipping
Stuart J. Tipping is a scholar working on Oncology, Molecular Biology, Neurology, Pollution and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 584 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Thallium and Germanium Studies (2 papers), Chemotherapy-induced organ toxicity mitigation (1 paper), Autoimmune Neurological Disorders and Treatments (1 paper), Polyomavirus and related diseases (1 paper), Cancer therapeutics and mechanisms (1 paper) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Oncology (244 citations), Pathology and Forensic Medicine (136 citations), Neurology (100 citations), Ophthalmology (55 citations) and Hematology (45 citations). Stuart J. Tipping has collaborated with scholars based in United States and Canada. Frequent co-authors include Daniel M. Jacobson, Charles E. Thirkill, David A. Van Echo, Eve A. Olman, Margaret Whitacre, Joseph Aisner, Merrill J. Egorin, Bruce Thompson, Roy E. Smith and Enrique Davila. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Neurology, American Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.